Loading...
Exosomal PD-L1 promotes tumor growth through immune escape in non-small cell lung cancer
Programmed cell death protein-1/programmed cell death ligand-1 (PD-1/PD-L1) pathway blockade is a promising new cancer therapy. Although PD-1/PD-L1 treatment has yielded clinical benefits in several types of cancer, further studies are required to clarify predictive biomarkers for drug efficacy and...
Na minha lista:
| Udgivet i: | Exp Mol Med |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Nature Publishing Group UK
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6802663/ https://ncbi.nlm.nih.gov/pubmed/31399559 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s12276-019-0295-2 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|